Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ADVERTISEMENT

Donepezil’s Effects on Brain Regions

Donepezil is an acetylcholinesterase inhibitor1. Acetylcholinesterase breaks down the neurotransmitter acetylcholine2, thereby reducing acetylcholine signalling in the brain. Acetylcholine (ACh) enhances the encoding of new memories and therefore improves learning3. Donepezil improves cognitive performance in mild cognitive impairment (MCI) and Alzheimer’s disease (AD), and is the most commonly prescribed acetylcholinesterase inhibitor (AChEI) for AD4. The effects of donepezil on the volumes of brain regions has been examined and may help explain its efficacy4.

In a recent study comparing healthy controls, untreated MCI patients and MCI patients treated with donepezil, volumes of brain regions and tests evaluating cognitive function were determined at baseline and 6 months post-initiation of treatment for the treated MCI group4. Donepezil improved scores on tests of cognitive function by minorly reducing ratings on geriatric depression and AD assessment scale-cognitive subscale, whilst significantly reducing clinical dementia rating by 14.1% and significantly increasing score on Korean version of the mini-mental state examination by 8% in 6 months4.

Grey matter (GM) volumes significantly increased post-treatment of donepezil in the putamen, globus pailldus, and inferior frontal gyrus regions of the brain but did not significantly differ from the untreated group when examining volume of the hippocampus4. However, longer duration of treatment with donepezil seems to reduce the rate of loss of hippocampal volume4.

These positive effects of donepezil on the brain may be explained through an increase in growth factors in the brain such as an increase in brain-derived neurotrophic factor (BDNF) seen in rats treated with donepezil4. BDNF increases neuronal survival, differentiation and synaptic plasticity, whilst promoting the breakdown of beta-amyloid plaque which is believed to contribute to AD4. The effects of BDNF provide a pro-cognitive, neuroprotective effect5. This increase in BDNF from donepezil is likely due to its pro-cholinergic signalling because cholinergic agonists increase BDNF expression as well as nerve growth factor (NGF) expression6, which shows the importance of cholinergic signalling for brain health.

***

References:  

  1. Kumar A, Sharma S. Donepezil. [Updated 2020 Aug 22]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513257/ 
  1. Trang A, Khandhar PB. Physiology, Acetylcholinesterase. [Updated 2020 Jul 10]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539735/ 
  1. Hasselmo M. E. (2006). The role of acetylcholine in learning and memory. Current opinion in neurobiology16(6), 710–715. https://doi.org/10.1016/j.conb.2006.09.002 
  1. Kim, GW., Kim, BC., Park, K.S. et al. A pilot study of brain morphometry following donepezil treatment in mild cognitive impairment: volume changes of cortical/subcortical regions and hippocampal subfields. Sci Rep 10, 10912 (2020). https://doi.org/10.1038/s41598-020-67873-y 
  1. Miranda, M., Morici, J. F., Zanoni, M. B., & Bekinschtein, P. (2019). Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Frontiers in cellular neuroscience13, 363. https://doi.org/10.3389/fncel.2019.00363 
  1. da Penha Berzaghi M, Cooper J, Castrén E, Zafra F, Sofroniew M, Thoenen H, Lindholm D. Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J Neurosci. 1993 Sep;13(9):3818-26. doi: https://doi.org/10.1523/JNEUROSCI.13-09-03818.1993. PMID: 8366347; PMCID: PMC6576436. 

*** 

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.

Most Popular Articles

What Makes Ginkgo biloba Live for Thousand Years

Gingko trees lives for thousands years by evolving compensatory...

Science of “Fifth State of Matter”: Molecular Bose–Einstein Condensate (BEC) Achieved   

In a recently published report, the Will Lab team...

HEROES: A Charity Founded by NHS Workers to Help NHS Workers

Founded by NHS workers to help NHS workers, has...
- Advertisement -
92,636FansLike
47,270FollowersFollow
1,772FollowersFollow
30SubscribersSubscribe